Landscape of HTLV-1 in vitro diagnostic tests
Journal of Clinical Microbiology · 17.11.2026
DOI: 10.1128/jcm.00580-26 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, online erschienen am 17.11.2026. Verfasst von Carolina Rosadas und 20 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College London, London, United Kingdom. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imperial College London, Medical Research Council Canada, NIHR Imperial Biomedical Research Centre.
Abstract (Originalsprache)
The extent of regulatory-approved assays for in vitro diagnostics of human T-lymphotropic virus 1 (HTLV-1) remains largely undocumented. This study aimed to map the current landscape of HTLV-1 diagnostics in 13 countries to support the development of World Health Organization guidelines and aid countries in building effective public health responses. Through a review of regulatory records and consultations with government officials, we identified 25 screening assays and three confirmatory tests. While most assays used serum or plasma, two enzyme immunoassays in Brazil were approved for antibody detection in dried blood spots. Only Japan had registered a rapid diagnostic test, which is based on immunochromatography. Screening assays generally had good performance, with both high sensitivity (range: 97.8%–100%) and specificity (range: 99.4%–100%). Assays using dried blood spots also had good performance with 96%–100% sensitivity and 98.7%–99.4% specificity. Three confirmatory, antibody-based tests were identified, but no molecular diagnostic tests were registered. The number of registered screening assays per country varied widely (range: 0–15), revealing a fragmentation and inconsistency in the global market. To foster an effective public health response, expanding access to and uptake of HTLV-1 testing services using accurate and quality-assured products is a priority.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Imperial College London, London, United Kingdom.
- World Health Organization, Geneva, Switzerland.
- Pan American Health Organization, Washington, DC, USA.
- Brazilian Ministry of Health, Brasilia, Brazil.
- St Marianna University School of Medicine, Kanagawa, Japan.
- National institute of Infectious diseases, Japan institute for Health Security, Tokyo, Japan.
ORCID-Profile: Carolina Rosadas, Philippa Hetzel
Förderung
- Imperial College London
- Medical Research Council Canada
- NIHR Imperial Biomedical Research Centre
Zitieren
APA
Rosadas, C., Sereno, L., Bajis, S., DiChiara, M. B., Baptista, C., Bigolin, A., Watanabe, T., Kuramitsu, M., Taylor, G. P., Sato, T., Yamano, Y., Saito, M., Bradshaw, D., Ducasa, N., Chidarikire, T., Garcia, P. J., Rowan, A., Vandegraaff, N., Biglione, M., …, & Johnson, C. (2026). Landscape of HTLV-1 in vitro diagnostic tests. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00580-26
Vancouver
Rosadas C, Sereno L, Bajis S, DiChiara MB, Baptista C, Bigolin A, et al. Landscape of HTLV-1 in vitro diagnostic tests. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.00580-26
BibTeX
@article{Rosadas2026,
author = {Rosadas, Carolina and Sereno, Leandro and Bajis, Sahar and DiChiara, Magdalena Barr and Baptista, Carlota and Bigolin, Alisson and Watanabe, Toshiki and Kuramitsu, Madoka and Taylor, Graham Phillip and Sato, Tomoo and Yamano, Yoshihisa and Saito, Masumichi and Bradshaw, Daniel and Ducasa, Nicolas and Chidarikire, Thato and Garcia, Patricia J and Rowan, Aileen and Vandegraaff, Nick and Biglione, Mirna and Hetzel, Philippa and Johnson, Cheryl},
title = {Landscape of HTLV-1 in vitro diagnostic tests},
journal = {Journal of Clinical Microbiology},
year = {2026},
doi = {10.1128/jcm.00580-26}
}
EUVIMED